SUMMARY
Although molecular components that execute non-inflammatory apoptotic cell death are well defined, molecular pathways that trigger necrotic cell death remain poorly characterized. Here we show that in response to infection with adenovirus or Listeria monocytogenes, macrophages in vivo undergo rapid pro-inflammatory necrotic death that is controlled by interferon-regulatory factor 3 (IRF3). The transcriptional activity of IRF3 is, surprisingly, not required for the induction of necrosis, and it proceeds normally in mice deficient in all known regulators of necrotic death or IRF3 activation, including RIPK3, Caspases-1, -8, or -11, STING and IPS1/MAVS. Although L.monocytogenes triggers necrosis to promote the infection, IRF3-dependent necrosis is required for reducing pathogen burden in the models of disseminated infection with adenovirus. Therefore, our studies implicate IRF3 as a principal and non-redundant component of a novel physiologically-regulated necrotic cell death pathway that operates as an effective innate immune mechanism of host protection against disseminated virus infection.
INTRODUCTION
Physiologically regulated cell death is a fundamental process in multi-cellular organisms that is critical for host survival. Although molecular components that execute non-inflammatory apoptotic cell death are well defined, molecular pathways that trigger regulated pro-inflammatory necrotic cell death remain poorly characterized. In response to pathogens, damage, or stress, cells can undergo capsase-1-dependent pro-inflammatory type of cell death called pyroptosis (Bergsbaken et al., 2009). Under the conditions when apoptotic caspases are blocked, in response to pleiotropic cytokine TNF-α or Fas-ligand, cells can undergo RIPK1-RIPK3-dependent necroptosis (Kaczmarek et al., 2013). Cells dieing via caspase-1-dependent pyroptosis and RIPK1-RIPK3-dependent necroptosis exhibit similar morphological changes that include lack of chromatin condensation and the loss of plasma membrane integrity.
Human adenovirus (HAdv) is a common human pathogen and for immunocompromized individuals, HAdv infections can be lethal (Kojaoghlanian et al., 2003). Accumulated data with using wild type HAdv species and HAdv-based vectors in pre-clinical studies and clinical gene therapy trials demonstrate that virus particles are efficiently cleared from the blood by resident liver macrophages Kupffer cells (Lieber et al., 1997; Morral et al., 2002). However, after interaction with the virus, Kupffer cells undergo rapid death (Manickan et al., 2006) and molecular pathways triggering this response and its physiological relevance remain undefined.
Here we show that IRF3 is a principal and non-redundant factor that triggers rapid necrotic macrophage cell death in vivo in response to disseminated infections with adenovirus or L.monocytogenes. The activation of this IRF3-dependent cell death is associated with the loss of plasma membrane integrity within minutes after the pathogen challenge and, remarkably, does not require IRF3-dependent gene expression. Although L.monocytogenes triggers IRF3-dependent necrosis to promote the infection, macrophage necrosis is required for reducing pathogen burden in the models of disseminated infection with adenovirus. Collectively, our studies reveal a novel physiologically-regulated necrotic cell death pathway that operates as an effective innate immune mechanism of host protection against disseminated virus infection.
RESULTS
HAdv triggers necrotic type of macrophage death in vivo, independently of caspase-1, caspase-8, caspase-11, and RIPK3
To classify the type of death that Kupffer cells undergo after exposure to HAdv (Galluzzi et al., 2012), we utilized an all in vivo approach and challenged mice deficient in principal mediators of the known specific regulated cell death mechanisms and immune pathways with the virus (Table S1). Intravenous injection of wild type HAdv into wild type mice resulted in efficient trapping of virus particles by CD68+ resident liver macrophages (Figure 1A). Furthermore, subsequent administration of mice with membrane impermeable dye propidium iodide (PI) revealed that nuclei of all CD68+ cells were stained PI-positive, demonstrating that these cells have lost their plasma membrane integrity (Figures 1B and S1A). Mice deficient in inflammatory and apoptotic caspases demonstrated no reduction in sensitivity of liver macrophages to HAdv challenge (Figure 1C). HAdv administration to mice deficient in various inflammatory cytokines, toll-like receptors, cathepsins -B, -L, and -S, superoxide producing NADPH oxidase components p47Phox and gp91Phox, pro-apoptotic proteins BAK and BAX, or mitochondrial Cyclophillin D (Ppif-/-) showed lack of resistance of liver macrophages to the virus (Figures S1C-F). Furthermore, HAdv administration to mice deficient in key mediators of pyronecrosis (ASC-deficient Pycard-/-), necroptosis (Ripk3-/- and Casp8-/-/Ripk3-/-), stress response PIDDosome (RAIDD-deficient mice, Cradd-/-), Myd88-/-, and Ticam1-/- demonstrated their sensitivity to the virus (Figure 1D). The analysis of the kinetics of plasma membrane integrity loss revealed that within 10 minutes after the virus administration, nuclei of all liver macrophages became PI-positive (Figure 1E). Ultrastructural analysis of liver macrophages 15 minutes after the virus challenge revealed catastrophic disorganization of the cytosol and swollen mitochondria (Figures 1F). Administration of HAdv into mice also resulted in significant increase in the amount of cytosolic enzyme lactate dehydrogenase (LDH) in plasma, compared to saline-injected group (Fig. 1G). Collectively, the ultrastructural changes, along with the loss of the plasma membrane integrity, are consistent with morphological and functional changes associated with necrotic forms of cell death (Ting et al., 2008). However, this necrotic-type cell death occurs with extremely rapid kinetics and independently of the known principal mediators that execute both apoptotic and necrotic cell death programs (Galluzzi et al., 2012).
Macrophages in Irf3-/- are resistant to virus-induced necrotic cell death
Next we extended our analyses to mice deficient in mediators of virus infection-sensing pathways. This analysis revealed that in mice deficient in transcriptional factor interferon regulatory factor 3 (IRF3) (Sato et al., 2000), liver macrophages were resistant to HAdv-induced cell death (Figures 2A-C, and S2). Furthermore, in Irf3-/- mice, CD68+ cells were present in the liver parenchyma even 24 hours after the virus challenge (Figures 2B-C). Surprisingly, CD68+ cells in the livers of mice deficient in IPS-1/MAVS/VISA (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) and STING (Ishikawa and Barber, 2008; Sauer et al., 2011b), that operate upstream of IRF3 in viral genome-sensing pathways, as well as in mice deficient in cytosolic DNA sensor DAI (Zbp1-/-) (Takaoka et al., 2007) were sensitive to HAdv challenge (Figures 2A-B).
Because activation of IRF3 as a transcription activation factor associates with its phosphorylation at Ser396 (Yoneyama et al., 2002), we analyzed whether IRF3 is phosphorylated at Ser396 by the time of macrophage cell death. Western blot analysis showed that IRF3 became phosphorylated at Ser396 in response to cell treatment with poly-I:C in vitro, however, Ser396 IRF3 phosphorylation was lacking in both saline and HAdv-treated mice (Figures 2D-E). The analysis of IRF3-dependent gene expression in the liver and spleen (Figures 2F-G) by 30 minutes after the virus challenge further revealed the lack of transcriptional activation of IRF3-dependent genes.
Necrotic-type cell death associates with systemic inflammatory response syndrome that can be lethal to the host (Kaczmarek et al., 2013). Therefore, we challenged WT and Irf3-/- mice with HAdv and analyzed plasma cytokines and chemokines 1 hour after virus administration. This analysis showed that numerous pro-inflammatory cytokines and chemokines, including IL-1α, IL-16, GM-CSF, CCL1, CCL4, CCL11, CXCL1 and CXCL2, were elevated in plasma of WT, but not Irf3-/- mice after the virus challenge (Figure 2H-I). Consistent with the reduced levels of cytokines and chemokines, cytopenia (a clinical marker of systemic inflammatory response), was not observed in Irf3-/- mice after the virus challenge, while WT mice were highly cytopenic after the virus infection (Figure 2J).
IRF3 triggers macrophage necrosis upon pathogen entry into the cytosol
Earlier analyses suggested that HAdv entry into the cytosol is required for the induction of macrophage cell death in vivo (Smith et al., 2008). However, many viral and bacterial pathogens target cytosol as an effective reproductive niche within the cell. Therefore, we infected mice with wild type adenovirus serotypes HAdv2, HAdv5, replication-defective adenovirus vector Ad5GFP, or a single-point HAdv2 mutant ts1, that cannot escape from the endosomal compartment into the cytosol (Greber et al., 1993). We also infected mice with wild type Listeria monocytogenes as a representative facultative cytosolic bacterial pathogen or its isogenic mutant Δhly that lacks Listeriolysin O and fails to escape from the phagosomal compartment into the cytosol (Portnoy et al., 1988). The analysis of the loss of plasma membrane integrity by liver macrophages after WT mice infection with all of these pathogens showed that liver macrophages rapidly became PI-permeable in response to HAdv2, HAdv5, Ad5GFP vector, and L.monocytogenes infection (Figure 3A). However, both the ts1 adenovirus and Δhly L.monocytogenes mutant failed to induce permeability of liver macrophages to PI (Figures 3A and S3). Remarkably, macrophages in Irf3-/- mice did not lose plasma membrane integrity after infection with all of these pathogens (Figures 3A-C and S3). We further confirmed that CD68+ liver macrophages efficiently sequester L.monocytogenes from the blood (Figure 3B), and liver macrophage permeability to the PI after L.monocytogenes infection associates with elevated LDH levels in plasma in WT but not Irf3-/- mice, demonstrating that upon entry into macrophages in vivo, L.monocytogenes triggers genuine and rapid physiologically-regulated necrosis, that requires pathogen entry into the cytosol. Similar to results observed with mouse infection with HAdv, we found that liver macrophages became PI-permeable after L.monocytogenes infection of mice deficient in inflammasome components ASC, Caspase-1 and -11, Cathepsin-B, STING, and IPS1/MAVS, but not in Irf3-/- mice (Fig. 3E). Collectively, these data demonstrate that IRF3 triggers necrosis in vivo in response to both HAdv and L.monocytogenes infection. Furthermore, pathogen penetration into the cytosol is required to induce this form of necrosis.
IRF3-dependent “defensive suicide” is a protective macrophage effector mechanism against disseminated virus infection
To analyze functional relevance of IRF3-dependent macrophage necrosis for host defense against disseminated infections, we first infected WT and Irf3-/- mice with L.monocytogenes and analyzed pathogen burden in the liver 6 h post infection. This analysis showed that the bacterial burden doubled over this timeframe, but only in WT and not in Irf3-/- mice (Figure 4A). In contrast, upon infection of WT and Irf3-/- mice with wild type HAdv5, 24 h post infection, the pathogen burden was significantly higher in the livers of mice deficient in IRF3, compared to control WT mice (Figure 4B).
The observation that macrophages induce IRF3-dependent necrotic death within minutes after interaction with HAdv may indicate that this form of regulated necrosis functionally represents a “defensive suicide” strategy that must be effective at enabling immunity to disseminated virus infection. Consequently, for the host that lacks this macrophage population, even a sub-lethal virus infection may lead to compromised resistance and be detrimental to survival. To experimentally evaluate this assumption, we depleted wild type mice of tissue macrophages with clodronate liposomes prior to their challenge with escalating sub-lethal doses of the wild type HAdv5 and compared the virus burden in the liver 48 hours after virus administration. This analysis revealed that in mice depleted of tissue macrophages, there was 2 to 3 orders of magnitude higher virus DNA burden compared to mice with liver macrophages intact (Figure 4C). The serum levels of liver enzymes ALT and AST, indicating virus-induced hepatotoxicity, were significantly (up to 10-fold) higher in macrophage-depleted mice, compared to mice with tissue macrophages (Figure 4D). Furthermore, depletion of tissue macrophages from mice resulted in over 10-fold reduction in LD50, extensive histologically-evident liver damage, virus replication and protein expression (Figs. 4E-G). At a sub-lethal doses of 1010 and 1011 virus particles per mouse, the majority of macrophage-containing mice survived the infection for the duration of the experiment (250 hours post virus infection), while 100% of macrophage-depleted mice succumbed by 75 hours (P<0.0006) (Fig. 4H). Collectively, these data provide experimental evidence that HAdv-triggered macrophage cell death effectively reduces the virus burden and protects the host from sub-lethal doses of disseminated virus in vivo.
DISCUSSION
In this study we implicated IRF3 as a critical and non-redundant factor required for the execution of novel necrotic cell death type that ensues in response to viral and bacterial pathogens. We found that upon triggering necrotic death, IRF3 does not function as a transcription activating factor. Although IRF3 can be activated downstream of the IPS1/MAVS/VISA- and STING-mediated viral genome sensing pathway as well as TBK1/IKKε signaling in various cell types (Fitzgerald et al., 2003; Takeuchi and Akira, 2009), our data indicate that in the context of IRF3-dependent necrosis, both IPS1/MAVS and STING, as well as BAK and BAX (Chattopadhyay et al., 2010; Chattopadhyay et al., 2011) are all dispensable for the induction and execution of cell death in vivo. Using the entirely genetic evidence in mice deficient in Cathepsin B, inflammasome component ASC (that is required for NLRP3-mediated inflammasome activation), Caspases-1 and -11, as well as ROS-producing NADPH-oxidase components p47Phox and gp91Phox, we found that liver macrophages rapidly lose their plasma membrane integrity after HAdv infection indicating that IRF3-dependent necrosis is a distinct pathway and requires none of these components to ensue in vivo.
Caspase-1-dependent pyroptosis is an important host defense mechanism and constitutes a necrotic-type cell death that ablates the niche for pathogen replication (Bergsbaken et al., 2009). However, pyroptosis per se does not result in the reduction of pathogen burden and, to control the infection, bacteria released from pyroptotic cells in vivo are killed by bactericidal effectors produced by host's neutrophils (Miao et al., 2010). Here we showed that the induction of IRF3-dependent necrosis in vivo does not result in the reduction of L.monocytogenes burden in the liver but, rather, it supports the infection. It is noteworthy that L.monocytogenes that was engineered to ectopically expresses Legionella pneumophila flagellin and, therefore, became highly efficient at activating NLRC4 inflammasome, in vivo exhibited a severely attenuated phenotype, compared to parental L.monocytogenes strain (Sauer et al., 2011a). Together this data suggests that bacterial pathogens may have evolved specific mechanisms to activate pro-inflammatory nectoric-type cell death in vivo to propagate the infection, likely via the recruitment of pathogen-susceptible monocytes. However, a delicate balance may exist where an excessive or untimely pro-inflammatory cell death limits pathogen survival.
The unique feature of the IRF3-dependent necrosis is its extremely rapid kinetic that enables host protection from disseminated virus infection. RIPK1-RIPK3-dependent necroptosis was shown to play a key role in development and immunity (Declercq et al., 2009; Green et al., 2011). However, in response to physiological stimuli, necroptosis occurs with much slower kinetics and was shown to be targeted by specific viral genes to prevent cell death execution (Upton et al., 2010; Upton et al., 2012). Our finding of IRF3-dependent cell death may also be relevant to conditions and pathologies beyond host responses to disseminated infections with viral and bacterial pathogens. The development of specific pharmacological inhibitors of this novel regulated necrotic cell death type may reveal its contribution and be found useful for the treatment of inflammatory diseases and conditions where underlying pathology is associated with perpetual cycles of pro-inflammatory cell death.
EXPERIMENTAL PROCEDURES
All animal studies were carried out with the approval of the Institutional Animal Care and Use Committee of the University of Washington, Seattle, WA. C57BL/6 mice were purchased from Charles River, Wilmington, MA. All mice were on C57BL/6 genetic background, matched by age and housed in specific-pathogen-free facilities. Mice were infected with wild type HAdv at a dose of 1×1010 virus particles per mouse via tail vein infusion. Viral particle titers were determined by OD260 measurement. For in vivo experiments, only virus preparations confirmed to be free of endotoxin contamination were used. L.monocytogenes and isogenic Δhly strains were grown on BHI plates from frozen stocks. Stationary cultures were initiated from single colonies and incubated at 30C overnight. Two to 4 hours prior to bacteria administration into mice at a dose of 108 CFU via the tail vein infusion, fresh cultures were initiated and incubated at 37C with shaking as described in (Sauer et al., 2011a). Bacteria titers were measured by optical density and verified by plating serial 10-fold dilutions on BHI plates. Administration of this dose of L.monocytogenes into the bloodstream resulted in deposition of 1-2 visible bacterial cells per liver macrophage (determined by injecting CFSC-labeled bacteria). Proteome Profiler antibody array “Mouse Cytokine Array Panel A” (#ARY006) was from R&D Systems and was used according to the manufacturer's instructions. Unless otherwise noted, statistical analysis in each independent experiment was performed with an unpaired, two-tailed Student's t-test. Data are reported as mean ± standard deviation. P < 0.05 was considered statistically significant. Animal survival was analyzed using log-rank test and GraphPad Prism 5 software.
Supplementary Material
Highlights.
IRF3 is a critical and non-redundant factor that executes necrotic death in vivo.
IRF3 executes necrosis independently of its transcription activator function.
IRF3-dependent necrotic cell death is distinct from pyroptosis and necroptosis.
IRF3-dependent necrosis protects the host from disseminated virus infection.
ACKNOWLEGEMENTS
We thank Drs. V. Dixit (Roche, CA) for Pycard-/- and Ripk3-/-, R.A. Flavell (Yale University, CT) for Casp1/11-/-, S. Akira (Osaka University, Japan) for Myd88-/-, Tlr4-/-, Tlr7/8-/-, Tlr9-/-, and Zbp1-/-, R.Vance (University of California, Berkeley, CA) for Tmem173Gt/Gt, M. Gale Jr. (University of Washington, WA) for Sti-/- (Mavs-/-), R. Hakem (University of Toronto, ON, Canada) for Casp8fl/fl, S. Hedrick (University of California, San Diego, CA) for Casp8fl/fl, D. Green (St. Jude Children's Research Hospital, Memphis, TN) for Casp8-/-Ripk3-/-, T. Mak (University Health Network, ON, Canada) for Cradd-/-, T. Reinheckel (Albert-Ludwigs-University Freiburg, Freiburg, Germany) and J. Joyce (Memorial Sloan-Kettering Cancer Center, NY) for Ctsb-/-, Ctss-/- and Ctsl-/-, Y. Iwakura (University of Tokyo, Japan) for Il1a-/- and Il1a/b-/-, D. Chaplin (University of Alabama, AL) for Il1b-/-, M. Wewers (Ohio State University, OH) for Il1b-/-/Il18-/-, and T. Taniguchi (University of Tokyo) for Irf3-/- mice . We are thankful to A. Byrnes (US Food and Drug Administration) for providing ts1 virus. L.monocytogenes (10403S) and isogenic Δhly strains were provided by E. Miao (University of North Carolina, Chapel Hill, USA) and A. Aderem (SeattleBiomed, USA). This study was supported by US NIH grants AI065429 and CA141439 to D.M.S.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, three figures, one table, and supplemental references and can be found with this article online at http://
REFERENCES
- Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nature Reviews Microbiology. 2009;7:99–109. doi: 10.1038/nrmicro2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A, Williams BRG, Sen GC. Viral apoptosis is induced by IRF-3-mediated activation of Bax. Embo Journal. 2010;29:1762–1773. doi: 10.1038/emboj.2010.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chattopadhyay S, Yamashita M, Zhang Y, Sen GC. The IRF-3/Bax-Mediated Apoptotic Pathway, Activated by Viral Cytoplasmic RNA and DNA, Inhibits Virus Replication. Journal of Virology. 2011;85:3708–3716. doi: 10.1128/JVI.02133-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Declercq W, Vanden Berghe T, Vandenabeele P. RIP Kinases at the Crossroads of Cell Death and Survival. Cell. 2009;138:229–232. doi: 10.1016/j.cell.2009.07.006. [DOI] [PubMed] [Google Scholar]
- Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003;4:491–496. doi: 10.1038/ni921. [DOI] [PubMed] [Google Scholar]
- Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death and Differentiation. 2012;19:107–120. doi: 10.1038/cdd.2011.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greber UF, Willetts M, Webster P, Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 1993;75:477–486. doi: 10.1016/0092-8674(93)90382-z. [DOI] [PubMed] [Google Scholar]
- Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS. RIPK-Dependent Necrosis and Its Regulation by Caspases: A Mystery in Five Acts. Molecular Cell. 2011;44:9–16. doi: 10.1016/j.molcel.2011.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling (vol 455, pg 674, 2008). Nature. 2008;456:274–274. doi: 10.1038/nature07317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38:209–223. doi: 10.1016/j.immuni.2013.02.003. [DOI] [PubMed] [Google Scholar]
- Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunology. 2005;6:981–988. doi: 10.1038/ni1243. [DOI] [PubMed] [Google Scholar]
- Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol. 2003;13:155–171. doi: 10.1002/rmv.386. [DOI] [PubMed] [Google Scholar]
- Lieber A, He CY, Meuse L, Schowalter D, Kirillova I, Winther B, Kay MA. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol. 1997;71:8798–8807. doi: 10.1128/jvi.71.11.8798-8807.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manickan E, Smith JS, Tian J, Eggerman TL, Lozier JN, Muller J, Byrnes AP. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Molecular Therapy. 2006;13:108–117. doi: 10.1016/j.ymthe.2005.08.007. [DOI] [PubMed] [Google Scholar]
- Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp R. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005;437:1167–1172. doi: 10.1038/nature04193. [DOI] [PubMed] [Google Scholar]
- Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nature Immunology. 2010;11:1136–U1194. doi: 10.1038/ni.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morral N, O'Neal WK, Rice K, Leland MM, Piedra PA, Aguilar-Cordova E, Carey KD, Beaudet AL, Langston C. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther. 2002;13:143–154. doi: 10.1089/10430340152712692. [DOI] [PubMed] [Google Scholar]
- Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med. 1988;167:1459–1471. doi: 10.1084/jem.167.4.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13:539–548. doi: 10.1016/s1074-7613(00)00053-4. [DOI] [PubMed] [Google Scholar]
- Sauer JD, Pereyre S, Archer KA, Burke TP, Hanson B, Lauer P, Portnoy DA. Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc Natl Acad Sci U S A. 2011a;108:12419–12424. doi: 10.1073/pnas.1019041108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sauer JD, Sotelo-Troha K, von Moltke J, Monroe KM, Rae CS, Brubaker SW, Hyodo M, Hayakawa Y, Woodward JJ, Portnoy DA, Vance RE. The N-Ethyl-N-Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic Dinucleotides. Infection and Immunity. 2011b;79:688–694. doi: 10.1128/IAI.00999-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seth RB, Sun LJ, Ea CK, Chen ZJJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappa B and IRF3. Cell. 2005;122:669–682. doi: 10.1016/j.cell.2005.08.012. [DOI] [PubMed] [Google Scholar]
- Smith JS, Xu ZL, Tian J, Stevenson SC, Byrnes AP. Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver. Human Gene Therapy. 2008;19:547–554. doi: 10.1089/hum.2008.004. [DOI] [PubMed] [Google Scholar]
- Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007;448:501–U514. doi: 10.1038/nature06013. [DOI] [PubMed] [Google Scholar]
- Takeuchi O, Akira S. Innate immunity to virus infection. Immunological Reviews. 2009;227:75–86. doi: 10.1111/j.1600-065X.2008.00737.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ting JPY, Willingham SB, Bergstralh DT. NLRs at the intersection of cell death and immunity. Nature Reviews Immunology. 2008;8:372–379. doi: 10.1038/nri2296. [DOI] [PubMed] [Google Scholar]
- Upton JW, Kaiser WJ, Mocarski ES. Virus Inhibition of RIP3-Dependent Necrosis. Cell Host & Microbe. 2010;7:302–313. doi: 10.1016/j.chom.2010.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA. Cell Host & Microbe. 2012;11:290–297. doi: 10.1016/j.chom.2012.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu LG, Wang YY, Han KJ, Li LY, Zhai ZH, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Molecular Cell. 2005;19:727–740. doi: 10.1016/j.molcel.2005.08.014. [DOI] [PubMed] [Google Scholar]
- Yoneyama M, Suhara W, Fujita T. Control of IRF-3 activation by phosphorylation. Journal of Interferon and Cytokine Research. 2002;22:73–76. doi: 10.1089/107999002753452674. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.